Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
28.80
Dollar change
+0.59
Percentage change
2.09
%
IndexRUT P/E74.21 EPS (ttm)0.39 Insider Own4.24% Shs Outstand14.15M Perf Week-0.07%
Market Cap410.11M Forward P/E571.09 EPS next Y0.05 Insider Trans0.00% Shs Float13.63M Perf Month-13.41%
Income5.52M PEG7.42 EPS next Q-0.35 Inst Own91.97% Short Float3.24% Perf Quarter-22.46%
Sales138.20M P/S2.97 EPS this Y-721.05% Inst Trans0.25% Short Ratio10.32 Perf Half Y-8.43%
Book/sh8.58 P/B3.36 EPS next Y105.08% ROA3.15% Short Interest0.44M Perf Year49.77%
Cash/sh2.47 P/C11.66 EPS next 5Y10.00% ROE4.81% 52W Range16.79 - 39.41 Perf YTD-20.77%
Dividend Est.- P/FCF41.59 EPS past 5Y20.22% ROI3.56% 52W High-26.92% Beta1.01
Dividend TTM- Quick Ratio3.97 Sales past 5Y11.28% Gross Margin76.85% 52W Low71.53% ATR (14)1.10
Dividend Ex-Date- Current Ratio4.84 EPS Y/Y TTM116.92% Oper. Margin9.05% RSI (14)43.99 Volatility3.02% 3.41%
Employees376 Debt/Eq0.28 Sales Y/Y TTM35.65% Profit Margin3.99% Recom1.00 Target Price59.00
Option/ShortYes / Yes LT Debt/Eq0.27 EPS Q/Q90.07% Payout- Rel Volume0.75 Prev Close28.21
Sales Surprise3.06% EPS Surprise100.00% Sales Q/Q22.54% EarningsFeb 01 BMO Avg Volume42.72K Price28.80
SMA20-2.21% SMA50-8.86% SMA200-11.56% Trades Volume32,256 Change2.09%
Date Action Analyst Rating Change Price Target Change
Jun-13-23Upgrade Needham Hold → Buy $36
Feb-13-23Downgrade Needham Buy → Hold
Jul-23-20Upgrade Needham Hold → Buy
Dec-11-19Downgrade Needham Buy → Hold
Nov-01-19Downgrade Lake Street Buy → Hold $75 → $50
Aug-01-19Reiterated Needham Buy $65 → $68
May-02-19Reiterated Needham Buy $74 → $65
May-02-19Reiterated Lake Street Buy $90 → $75
Feb-21-19Reiterated Needham Buy $69 → $74
May-16-18Reiterated Needham Buy $46 → $55
Mar-20-24 11:29AM
Feb-27-24 08:00AM
Feb-02-24 10:11AM
09:58AM
Feb-01-24 01:03PM
09:30AM Loading…
09:30AM
08:10AM
07:11AM
07:00AM
Jan-23-24 10:15AM
Jan-22-24 07:30AM
Jan-16-24 07:30AM
07:30AM
Dec-14-23 07:14AM
Dec-12-23 11:31AM
07:30AM Loading…
Nov-16-23 07:30AM
07:30AM
Nov-14-23 04:05PM
Nov-11-23 02:10PM
Nov-09-23 12:44PM
12:33AM
Nov-08-23 03:10PM
09:30AM
08:00AM
07:30AM
Nov-07-23 07:30AM
07:30AM
Oct-31-23 07:30AM
Oct-10-23 11:28AM
07:30AM
10:42AM Loading…
Sep-12-23 10:42AM
Sep-06-23 11:04AM
Aug-15-23 10:20AM
Aug-09-23 05:05PM
Aug-03-23 01:03PM
06:47AM
Aug-02-23 09:30AM
08:55AM
07:47AM
07:31AM
Jul-26-23 10:02AM
Jul-12-23 07:30AM
Jun-28-23 11:31AM
Jun-23-23 10:27AM
Jun-21-23 06:10AM
01:53AM
Jun-20-23 11:54AM
06:30AM
Jun-16-23 11:20AM
Jun-14-23 07:30AM
01:18AM
Jun-13-23 01:11PM
May-25-23 04:05PM
May-16-23 09:55AM
May-15-23 09:35AM
May-14-23 08:21AM
May-03-23 01:35PM
Apr-27-23 10:29AM
12:23AM
Apr-26-23 08:25AM
07:00AM
Apr-20-23 07:05AM
Apr-19-23 07:30AM
07:00AM
Apr-17-23 06:29AM
Apr-11-23 08:30AM
Apr-10-23 06:50AM
Apr-06-23 10:35AM
Mar-29-23 08:44AM
Mar-28-23 09:25AM
Mar-17-23 08:38AM
Mar-08-23 11:30AM
08:30AM
Mar-06-23 10:13AM
Mar-03-23 06:56PM
Feb-07-23 09:52AM
Feb-06-23 06:15PM
04:05PM
Feb-03-23 05:11AM
Jan-31-23 10:00AM
08:30AM
Jan-26-23 10:01AM
08:30AM
Jan-24-23 07:57AM
Jan-23-23 09:04AM
Jan-19-23 09:52AM
08:30AM
07:00AM
Jan-16-23 08:30AM
Dec-30-22 09:31AM
Nov-17-22 08:30AM
Nov-11-22 08:30AM
05:53AM
Nov-10-22 08:35AM
Nov-09-22 08:35AM
07:00AM
Nov-02-22 08:30AM
Oct-28-22 07:30AM
Oct-26-22 08:30AM
Oct-17-22 08:30AM
Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures vascular interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEDOYA JOSE HDirectorFeb 08 '24Option Exercise23.953,93294,17130,108Feb 12 04:18 PM
KNIGHT SUSAN EDirectorFeb 05 '24Option Exercise23.953,93294,17136,267Feb 07 04:27 PM
DANTZKER DAVIDDirectorJan 19 '24Option Exercise23.953,93294,17140,094Jan 23 05:46 PM
KALICH RONALD B SRDirectorDec 27 '23Option Exercise23.953,93294,17138,529Dec 29 04:26 PM
Stich Joseph J.SVP HR and IVDNov 15 '23Option Exercise23.9517,121410,04872,433Nov 17 04:07 PM
OLSON CHARLES WSVP, Medical Device CoatingsNov 15 '23Option Exercise23.9512,841307,54258,937Nov 17 04:06 PM